ATC code M01

ATC codes

M01 Anti-inflammatory and antirheumatic products

M02 Topical products for joint and muscular pain

M04 Antigout preparations

M05 Drugs for treatment of bone diseases

M09 Other drugs for disorders of the musculo-skeletal system

ATC code M01 Anti-inflammatory and antirheumatic products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup M01 is part of the anatomical group M Musculo-skeletal system.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QM01...^[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M01A Anti-inflammatory and antirheumatic products, non-steroids

M01AA Butylpyrazolidines

M01AA01 Phenylbutazone

M01AA02 Mofebutazone

M01AA03 Oxyphenbutazone

M01AA05 Clofezone

M01AA06 Kebuzone

QM01AA90 Suxibuzone

QM01AA99 Combinations

M01AB Acetic acid derivatives and related substances

M01AB01 Indometacin

M01AB02 Sulindac

M01AB03 Tolmetin

M01AB04 Zomepirac

M01AB05 Diclofenac

M01AB06 Alclofenac

M01AB07 Bumadizone

M01AB08 Etodolac

M01AB09 Lonazolac

M01AB10 Fentiazac

M01AB11 Acemetacin

M01AB12 Difenpiramide

M01AB13 Oxametacin

M01AB14 Proglumetacin

M01AB15 Ketorolac

M01AB16 Aceclofenac

M01AB17 Bufexamac

M01AB51 Indometacin, combinations

M01AB55 Diclofenac, combinations

M01AC Oxicams

M01AC01 Piroxicam

M01AC02 Tenoxicam

M01AC04 Droxicam

M01AC05 Lornoxicam

M01AC06 Meloxicam

M01AC56 Meloxicam, combinations

M01AE Propionic acid derivatives

M01AE01 Ibuprofen

M01AE02 Naproxen

M01AE03 Ketoprofen

M01AE04 Fenoprofen

M01AE05 Fenbufen

M01AE06 Benoxaprofen

M01AE07 Suprofen

M01AE08 Pirprofen

M01AE09 Flurbiprofen

M01AE10 Indoprofen

M01AE11 Tiaprofenic acid

M01AE12 Oxaprozin

M01AE13 Ibuproxam

M01AE14 Dexibuprofen

M01AE15 Flunoxaprofen

M01AE16 Alminoprofen

M01AE17 Dexketoprofen

M01AE18 Naproxcinod

M01AE51 Ibuprofen, combinations

M01AE52 Naproxen and esomeprazole

M01AE53 Ketoprofen, combinations

M01AE56 Naproxen and misoprostol

QM01AE90 Vedaprofen

QM01AE91 Carprofen

QM01AE92 Tepoxalin

M01AG Fenamates

M01AG01 Mefenamic acid

M01AG02 Tolfenamic acid

M01AG03 Flufenamic acid

M01AG04 Meclofenamic acid

QM01AG90 Flunixin

M01AH Coxibs

M01AH01 Celecoxib

M01AH02 Rofecoxib

M01AH03 Valdecoxib

M01AH04 Parecoxib

M01AH05 Etoricoxib

M01AH06 Lumiracoxib

QM01AH90 Firocoxib

QM01AH91 Robenacoxib

QM01AH92 Mavacoxib

QM01AH93 Cimicoxib

QM01AH94 Deracoxib

M01AX Other anti-inflammatory and antirheumatic agents, non-steroids

M01AX01 Nabumetone

M01AX02 Niflumic acid

M01AX04 Azapropazone

M01AX05 Glucosamine

M01AX07 Benzydamine

M01AX12 Glucosaminoglycan polysulfate

M01AX13 Proquazone

M01AX14 Orgotein

M01AX17 Nimesulide

M01AX18 Feprazone

M01AX21 Diacerein

M01AX22 Morniflumate

M01AX23 Tenidap

M01AX24 Oxaceprol

M01AX25 Chondroitin sulfate

M01AX26 Avocado and soybean oil, unsaponifiables

QM01AX52 Niflumic acid, combinations

M01AX68 Feprazone, combinations

QM01AX90 Pentosan polysulfate

QM01AX91 Aminopropionitrile

QM01AX99 Combinations

M01B Anti-inflammatory/antirheumatic agents in combination

M01BA Anti-inflammatory/antirheumatic agents in combination with corticosteroids

M01BA01 Phenylbutazone and corticosteroids

M01BA02 Dipyrocetyl and corticosteroids

M01BA03 Acetylsalicylic acid and corticosteroids

QM01BA99 Combinations

M01C Specific antirheumatic agents

References

↑ "ATC/DDD Index 2016: code M01". WHO Collaborating Centre for Drug Statistics Methodology.
↑ "ATCvet Index 2016: code QM01". WHO Collaborating Centre for Drug Statistics Methodology.

Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA)

Pyrazolones / Pyrazolidines	Aminophenazone Ampyrone Azapropazone Clofezone Famprofazone Feprazone Kebuzone Metamizole Mofebutazone Morazone Nifenazone Oxyphenbutazone Phenazone Phenylbutazone Propyphenazone Sulfinpyrazone Suxibuzone^‡

Salicylates	Aspirin (acetylsalicylic acid)^# Aloxiprin Benorylate Carbasalate calcium Diflunisal Dipyrocetyl Ethenzamide Guacetisal Magnesium salicylate Methyl salicylate Salsalate Salicin Salicylamide Salicylic acid (salicylate) Sodium salicylate

Acetic acid derivatives and related substances	Aceclofenac Acemetacin Alclofenac Amfenac Bendazac Bromfenac Bumadizone Bufexamac Diclofenac Difenpiramide Etodolac Felbinac Fentiazac Indomethacin Indomethacin farnesil Ketorolac Lonazolac Oxametacin Proglumetacin Sulindac Tolmetin Zomepirac^†

Oxicams	Ampiroxicam Droxicam Lornoxicam Meloxicam Piroxicam Tenoxicam

Propionic acid derivatives (profens)	Alminoprofen Benoxaprofen^† Carprofen^‡ Dexibuprofen Dexketoprofen Fenbufen Fenoprofen Flunoxaprofen Flurbiprofen Ibuprofen^# Ibuproxam Indoprofen^† Ketoprofen Loxoprofen Miroprofen Naproxen Oxaprozin Pirprofen Suprofen Tarenflurbil Tepoxalin^‡ Tiaprofenic acid Vedaprofen^‡ COX-inhibiting nitric oxide donator: Naproxcinod

N-Arylanthranilic acids (fenamates)	Azapropazone Etofenamate Flufenamic acid Flunixin Meclofenamic acid Mefenamic acid Morniflumate Niflumic acid Tolfenamic acid

Coxibs	Apricoxib Celecoxib Cimicoxib^‡ Deracoxib^‡ Etoricoxib Firocoxib^‡ Lumiracoxib^† Mavacoxib^‡ Parecoxib Robenacoxib^‡ Rofecoxib^† Valdecoxib^†

Other	Aminopropionitrile Benzydamine Chondroitin sulfate Diacerein Fluproquazone Glucosamine Glycosaminoglycan Hyperforin Nabumetone Nimesulide Oxaceprol Proquazone Superoxide dismutase/Orgotein Tenidap

Items listed in bold indicate initially developed compounds of specific groups. ^#WHO-EM ^†Withdrawn drugs. ^‡Veterinary use medications.

Specific antirheumatic products / DMARDs (M01C)

Quinolines	Oxycinchophen

Gold preparations	Sodium aurothiomalate Sodium aurothiosulfate Auranofin Aurothioglucose Aurotioprol

Other	Penicillamine #/Bucillamine Chloroquine #/Hydroxychloroquine Leflunomide Sulfasalazine # antifolate (Methotrexate #) thiopurine (Azathioprine) #

^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

This article is issued from Wikipedia - version of the Saturday, February 07, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.